Angiotensin-II Receptor Antagonists: New Generation Antihypertensives
The renin-angiotensin-aldosterone system (RAAS) has a central role in the expression and modulation of cardiovascular diseases, particularly, hypertension. The development of non-peptide, orally active angiotensin II receptor antagonists is the most recent focus area in antihypertensive drug development. Angiotensin II receptor antagonists/blockers (ARBs) are recognized as one of the most effective means of lowering blood pressure in hypertensive patients as these overcome the limitations of other drug classes such as angiotensin converting enzyme (ACE) inhibitors, beta blockers or renin inhibitors. ARBs offer cardiovascular and renal protect…
Mehr
CHF 96.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
- ISBN: 978-3-659-88487-0
- EAN: 9783659884870
- Produktnummer: 37415823
- Verlag: LAP Lambert Academic Publishing
- Sprache: Englisch
- Erscheinungsjahr: 2016
- Seitenangabe: 184 S.
- Masse: H22.0 cm x B15.0 cm x D1.1 cm 292 g
- Abbildungen: Paperback
- Gewicht: 292
Über den Autor
Alka Bali is an Associate Professor in Pharmaceutical Chemistry at University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India. She has been working in the area of synthetic medicinal chemistry with particular emphasis on development of novel angiotensin II antagonists, atypical antipsychotics and COX-2 inhibitors.
1 weiteres Werk von Alka Bali:
Bewertungen
Anmelden